Inventor
JOHNSON MICHAEL GARRETT
US12 patents
⚠️ This page may combine multiple inventors who share the name “JOHNSON MICHAEL GARRETT”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV TEXAS
7 patentsUS10421765B2Sep 24, 2019
Tetrahydropyrido[4,3-d]pyrimidine inhibitors of ATR kinase
UNIV TEXAS7 citations82
US10392376B2Aug 27, 2019
Heterocyclic inhibitors of ATR kinase
UNIV TEXAS7 citations82
US10800774B2Oct 13, 2020
Heterocyclic inhibitors of ATR kinase
UNIV TEXAS2 citations71
US10800769B2Oct 13, 2020
Heterocyclic inhibitors of ATR kinase
UNIV TEXAS2 citations71
US10745420B2Aug 18, 2020
Tetrahydropyrido[4,3-d]pyrimidine inhibitors of ATR kinase
UNIV TEXAS2 citations71
US11434233B2Sep 6, 2022
Heterocyclic inhibitors of ATR kinase
UNIV TEXAS0 citations61
US10894052B2Jan 19, 2021
Heterocyclic inhibitors of ATR kinase
UNIV TEXAS1 citations61
AMGEN INC
4 patentsUS11299479B1Apr 12, 2022
Bisamide sarcomere activating compounds and uses thereof
AMGEN INC8 citations83
US10899746B2Jan 26, 2021
Bisamide sarcomere activating compounds and uses thereof
AMGEN INC5 citations82
US10723720B2Jul 28, 2020
Bisamide sarcomere activating compounds and uses therof
AMGEN INC7 citations81
US11780826B2Oct 10, 2023
Bisamide sarcomere activating compounds and uses thereof
AMGEN INC2 citations71